Program Schedule

101
Antibacterials

Session: Symposium: New Anti-infective Clinical Trials That Will Change Your Practice
Thursday, October 9, 2014: 10:30 AM
Room: The Pennsylvania Convention Center: 115-ABC
Henry Chambers, MD, FIDSA, Medicine, University of California at San Francisco, San Francisco, CA

Dr. Chambers graduated from Vanderbilt University School of Medicine in 1977 where he was class valedictorian. He trained in Internal Medicine and Infectious Diseases at the University of California San Francisco. His was also a Kaiser Foundation Fellow in General Internal Medicine at UCSF and a post-doctoral research fellow at Rockefeller University. Dr. Chambers has been a member of the medical faculty of the UCSF since 1985 where he currently is Professor of Medicine and Director of Clinical Research Services for the UCSF Clinical Translational Research Insitutue. He served as Chief of Infectious Diseases at San Francisco General Hospital, from 1992-2013 and Director of the UCSF Infectious Diseases Fellowship Training Program from 2002-2013. He has co-chaired the Infection Control Committee and Antibiotic Advisory Committee at San Francisco General Hospital. He is a Fellow of the Infectious Diseases Society of America, the American College of Physicians, and was elected to membership in the American Society of Clinical Investigation. He is an editor for Antimicrobial Agents and Chemotherapy, a reviewer for numerous medical publications, and chairs the Clinical Research Field Stuides study section for NIH/NIAID. He has been a member of advisory groups for the Centers for Diseases Control and Prevention, a member of the IDSA treatment guidelines committee for skin and soft tissue infections and he co-chaired the IDSA guidelines committee for treatment of methicillin-resistant Staphylococcus aureus infections. He and Vance Fowler, MD, MPH, is Co-PI of the Antibacterial Resistance Leasdership Group. His clinical and research interests are antimicrobial drug resistance, staphylococcal infections, experimental therapeutics, and epidemiology and pathogenesis of disease caused by community methicillin-resistant Staphylococcus aureus. He is editor for the Sanford Guide to Antimicrobial Therapy and he has over 200 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases.



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek